Fairfax Financial Holdings »

Revance Therapeutics shares owned by Fairfax Financial Holdings

Quarter-by-quarter ownership of Revance Therapeutics shares owned by Fairfax Financial Holdings from 13F filings

Historical chart of Fairfax Financial Holdings investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Fairfax Financial Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Fairfax Financial Holdings

Quarter filed Position value Share count Share price at filing
2024-12-31 $64k 21k 3.03